HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 10-10-2020 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$18.15 CAGR » |
$385,464,527.25 21,237,715 shares |
| 4-17-2018 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$18.75 CAGR » |
$199,999,987.50 10,666,666 shares |
| 7-19-2017 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$8.00 CAGR » |
$25,000,000.00 3,125,000 shares |
Also See: Institutional Holders of AKCA
Also See: SEC filings
AKCA -- use the split history when considering split-adjusted past price performance.
Akcea Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Akcea Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AKCA
 Free AKCA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the Akcea Therapeutics Insider Buying occurred are:
Haverty Furniture Cos. Insider Buying
|
